Every investor in Ikena Oncology, Inc. (NASDAQ:IKNA) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies ...
Investors are always looking for stocks that are poised to beat at earnings season and Ikena Oncology, Inc. IKNA may be one such company. The firm has earnings coming up pretty soon, and events ...
BOSTON and SOUTH SAN FRANCISCO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (IKNA) (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient ...
Combined Company to Trade on Nasdaq Under Ticker "IMA" Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc.
About Ikena Oncology Ikena Oncology ® develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.
Ikena Oncology, Inc. 競合他社・同業他社分析 - Life Sciences セクター
Our AI model demonstrates 26% historical accuracy for IKNA predictions, based on advanced machine learning algorithms trained on over 10 years of market data.